List of Tables
Table 1. Global Neuroendocrine Tumor Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neuroendocrine Tumor Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neuroendocrine Tumor Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neuroendocrine Tumor Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Neuroendocrine Tumor Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neuroendocrine Tumor Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neuroendocrine Tumor Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neuroendocrine Tumor Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuroendocrine Tumor Drug, Product Type & Application
Table 12. Global Key Manufacturers of Neuroendocrine Tumor Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuroendocrine Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroendocrine Tumor Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuroendocrine Tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neuroendocrine Tumor Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Neuroendocrine Tumor Drug Sales Market Share by Region (2020-2025)
Table 19. Global Neuroendocrine Tumor Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Neuroendocrine Tumor Drug Sales Market Share by Region (2026-2031)
Table 21. Global Neuroendocrine Tumor Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Neuroendocrine Tumor Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Neuroendocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neuroendocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Neuroendocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Neuroendocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neuroendocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neuroendocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neuroendocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Neuroendocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Neuroendocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neuroendocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neuroendocrine Tumor Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neuroendocrine Tumor Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Neuroendocrine Tumor Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Neuroendocrine Tumor Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neuroendocrine Tumor Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neuroendocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neuroendocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Neuroendocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Neuroendocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neuroendocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neuroendocrine Tumor Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neuroendocrine Tumor Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Neuroendocrine Tumor Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Neuroendocrine Tumor Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neuroendocrine Tumor Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neuroendocrine Tumor Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Neuroendocrine Tumor Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Neuroendocrine Tumor Drug Sales Market Share by Type (2020-2025)
Table 53. Global Neuroendocrine Tumor Drug Sales Market Share by Type (2026-2031)
Table 54. Global Neuroendocrine Tumor Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neuroendocrine Tumor Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neuroendocrine Tumor Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Neuroendocrine Tumor Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Neuroendocrine Tumor Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Neuroendocrine Tumor Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Neuroendocrine Tumor Drug Sales Market Share by Application (2020-2025)
Table 63. Global Neuroendocrine Tumor Drug Sales Market Share by Application (2026-2031)
Table 64. Global Neuroendocrine Tumor Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neuroendocrine Tumor Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neuroendocrine Tumor Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Neuroendocrine Tumor Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Eisai Company Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Eisai Neuroendocrine Tumor Drug Product
Table 74. Eisai Recent Developments/Updates
Table 75. Exelixis, Inc. Company Information
Table 76. Exelixis, Inc. Description and Business Overview
Table 77. Exelixis, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Exelixis, Inc. Neuroendocrine Tumor Drug Product
Table 79. Exelixis, Inc. Recent Developments/Updates
Table 80. Foresee Pharmaceuticals, LLC Company Information
Table 81. Foresee Pharmaceuticals, LLC Description and Business Overview
Table 82. Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Product
Table 84. Foresee Pharmaceuticals, LLC Recent Developments/Updates
Table 85. Hutchison MediPharma Limited Company Information
Table 86. Hutchison MediPharma Limited Description and Business Overview
Table 87. Hutchison MediPharma Limited Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Hutchison MediPharma Limited Neuroendocrine Tumor Drug Product
Table 89. Hutchison MediPharma Limited Recent Developments/Updates
Table 90. Intezyne, Inc Company Information
Table 91. Intezyne, Inc Description and Business Overview
Table 92. Intezyne, Inc Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Intezyne, Inc Neuroendocrine Tumor Drug Product
Table 94. Intezyne, Inc Recent Developments/Updates
Table 95. INVENT Pharmaceuticals, Inc. Company Information
Table 96. INVENT Pharmaceuticals, Inc. Description and Business Overview
Table 97. INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product
Table 99. INVENT Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Ipsen S.A. Company Information
Table 101. Ipsen S.A. Description and Business Overview
Table 102. Ipsen S.A. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Ipsen S.A. Neuroendocrine Tumor Drug Product
Table 104. Ipsen S.A. Recent Developments/Updates
Table 105. Jiangsu Hengrui Medicine Co., Ltd. Company Information
Table 106. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
Table 107. Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Product
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
Table 110. Karyopharm Therapeutics, Inc. Company Information
Table 111. Karyopharm Therapeutics, Inc. Description and Business Overview
Table 112. Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Product
Table 114. Karyopharm Therapeutics, Inc. Recent Developments/Updates
Table 115. Lexicon Pharmaceuticals, Inc. Company Information
Table 116. Lexicon Pharmaceuticals, Inc. Description and Business Overview
Table 117. Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product
Table 119. Lexicon Pharmaceuticals, Inc. Recent Developments/Updates
Table 120. Midatech Pharma Plc . Company Information
Table 121. Midatech Pharma Plc . Description and Business Overview
Table 122. Midatech Pharma Plc . Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Midatech Pharma Plc . Neuroendocrine Tumor Drug Product
Table 124. Midatech Pharma Plc . Recent Developments/Updates
Table 125. Millennium Pharmaceuticals, Inc. Company Information
Table 126. Millennium Pharmaceuticals, Inc. Description and Business Overview
Table 127. Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Millennium Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Product
Table 129. Millennium Pharmaceuticals, Inc. Recent Developments/Updates
Table 130. MolMed S.p.A. Company Information
Table 131. MolMed S.p.A. Description and Business Overview
Table 132. MolMed S.p.A. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. MolMed S.p.A. Neuroendocrine Tumor Drug Product
Table 134. MolMed S.p.A. Recent Developments/Updates
Table 135. Northwest Biotherapeutics, Inc. Company Information
Table 136. Northwest Biotherapeutics, Inc. Description and Business Overview
Table 137. Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Northwest Biotherapeutics, Inc. Neuroendocrine Tumor Drug Product
Table 139. Northwest Biotherapeutics, Inc. Recent Developments/Updates
Table 140. Novartis AG Company Information
Table 141. Novartis AG Description and Business Overview
Table 142. Novartis AG Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Novartis AG Neuroendocrine Tumor Drug Product
Table 144. Novartis AG Recent Developments/Updates
Table 145. OctreoPharm Sciences GmbH Company Information
Table 146. OctreoPharm Sciences GmbH Description and Business Overview
Table 147. OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. OctreoPharm Sciences GmbH Neuroendocrine Tumor Drug Product
Table 149. OctreoPharm Sciences GmbH Recent Developments/Updates
Table 150. OXiGENE, Inc. Company Information
Table 151. OXiGENE, Inc. Description and Business Overview
Table 152. OXiGENE, Inc. Neuroendocrine Tumor Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. OXiGENE, Inc. Neuroendocrine Tumor Drug Product
Table 154. OXiGENE, Inc. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Neuroendocrine Tumor Drug Distributors List
Table 158. Neuroendocrine Tumor Drug Customers List
Table 159. Neuroendocrine Tumor Drug Market Trends
Table 160. Neuroendocrine Tumor Drug Market Drivers
Table 161. Neuroendocrine Tumor Drug Market Challenges
Table 162. Neuroendocrine Tumor Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neuroendocrine Tumor Drug
Figure 2. Global Neuroendocrine Tumor Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuroendocrine Tumor Drug Market Share by Type: 2024 & 2031
Figure 4. mTOR Protein Inhibitors Product Picture
Figure 5. Tyrosine Kinase 3 Inhibitors Product Picture
Figure 6. Somatostatin Receptor Antagonists Product Picture
Figure 7. Growth Hormone Releasing Factor Antagonists Product Picture
Figure 8. Somatostatin Receptor Agonists Product Picture
Figure 9. Others Product Picture
Figure 10. Global Neuroendocrine Tumor Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Neuroendocrine Tumor Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Neuroendocrine Tumor Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Neuroendocrine Tumor Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Neuroendocrine Tumor Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Neuroendocrine Tumor Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Neuroendocrine Tumor Drug Report Years Considered
Figure 20. Neuroendocrine Tumor Drug Sales Share by Manufacturers in 2024
Figure 21. Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Neuroendocrine Tumor Drug Players: Market Share by Revenue in Neuroendocrine Tumor Drug in 2024
Figure 23. Neuroendocrine Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Neuroendocrine Tumor Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Neuroendocrine Tumor Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Neuroendocrine Tumor Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Neuroendocrine Tumor Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Neuroendocrine Tumor Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Neuroendocrine Tumor Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Neuroendocrine Tumor Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Neuroendocrine Tumor Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Neuroendocrine Tumor Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Neuroendocrine Tumor Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Neuroendocrine Tumor Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Neuroendocrine Tumor Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Neuroendocrine Tumor Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Neuroendocrine Tumor Drug by Type (2020-2031)
Figure 60. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Neuroendocrine Tumor Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Neuroendocrine Tumor Drug by Application (2020-2031)
Figure 63. Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Neuroendocrine Tumor Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
